Global Oral Transmucosal Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Oral Transmucosal Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Oral Transmucosal Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Oral Transmucosal Drugs by Country/Region, 2017, 2022 & 2028

2.2 Oral Transmucosal Drugs Segment by Type

2.2.1 Tablets

2.2.2 Films

2.2.3 Liquid Spray

2.2.4 Gels

2.2.5 Others

2.3 Oral Transmucosal Drugs Sales by Type

2.3.1 Global Oral Transmucosal Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Oral Transmucosal Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Oral Transmucosal Drugs Sale Price by Type (2017-2022)

2.4 Oral Transmucosal Drugs Segment by Application

2.4.1 Cardiovascular Disorders

2.4.2 Acute Pain Managements

2.4.3 Diabetes

2.4.4 Others

2.5 Oral Transmucosal Drugs Sales by Application

2.5.1 Global Oral Transmucosal Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Oral Transmucosal Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Oral Transmucosal Drugs Sale Price by Application (2017-2022)

3 Global Oral Transmucosal Drugs by Company

3.1 Global Oral Transmucosal Drugs Breakdown Data by Company

3.1.1 Global Oral Transmucosal Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Oral Transmucosal Drugs Sales Market Share by Company (2020-2022)

3.2 Global Oral Transmucosal Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Oral Transmucosal Drugs Revenue by Company (2020-2022)

3.2.2 Global Oral Transmucosal Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Oral Transmucosal Drugs Sale Price by Company

3.4 Key Manufacturers Oral Transmucosal Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Oral Transmucosal Drugs Product Location Distribution

3.4.2 Players Oral Transmucosal Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Oral Transmucosal Drugs by Geographic Region

4.1 World Historic Oral Transmucosal Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Oral Transmucosal Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Oral Transmucosal Drugs Annual Revenue by Geographic Region

4.2 World Historic Oral Transmucosal Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Oral Transmucosal Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Oral Transmucosal Drugs Annual Revenue by Country/Region

4.3 Americas Oral Transmucosal Drugs Sales Growth

4.4 APAC Oral Transmucosal Drugs Sales Growth

4.5 Europe Oral Transmucosal Drugs Sales Growth

4.6 Middle East & Africa Oral Transmucosal Drugs Sales Growth

5 Americas

5.1 Americas Oral Transmucosal Drugs Sales by Country

5.1.1 Americas Oral Transmucosal Drugs Sales by Country (2017-2022)

5.1.2 Americas Oral Transmucosal Drugs Revenue by Country (2017-2022)

5.2 Americas Oral Transmucosal Drugs Sales by Type

5.3 Americas Oral Transmucosal Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Oral Transmucosal Drugs Sales by Region

6.1.1 APAC Oral Transmucosal Drugs Sales by Region (2017-2022)

6.1.2 APAC Oral Transmucosal Drugs Revenue by Region (2017-2022)

6.2 APAC Oral Transmucosal Drugs Sales by Type

6.3 APAC Oral Transmucosal Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Oral Transmucosal Drugs by Country

7.1.1 Europe Oral Transmucosal Drugs Sales by Country (2017-2022)

7.1.2 Europe Oral Transmucosal Drugs Revenue by Country (2017-2022)

7.2 Europe Oral Transmucosal Drugs Sales by Type

7.3 Europe Oral Transmucosal Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Oral Transmucosal Drugs by Country

8.1.1 Middle East & Africa Oral Transmucosal Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Oral Transmucosal Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Oral Transmucosal Drugs Sales by Type

8.3 Middle East & Africa Oral Transmucosal Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Oral Transmucosal Drugs

10.3 Manufacturing Process Analysis of Oral Transmucosal Drugs

10.4 Industry Chain Structure of Oral Transmucosal Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Oral Transmucosal Drugs Distributors

11.3 Oral Transmucosal Drugs Customer

12 World Forecast Review for Oral Transmucosal Drugs by Geographic Region

12.1 Global Oral Transmucosal Drugs Market Size Forecast by Region

12.1.1 Global Oral Transmucosal Drugs Forecast by Region (2023-2028)

12.1.2 Global Oral Transmucosal Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Oral Transmucosal Drugs Forecast by Type

12.7 Global Oral Transmucosal Drugs Forecast by Application

13 Key Players Analysis

13.1 LTS Lohmann Therapie-Systeme AG

13.1.1 LTS Lohmann Therapie-Systeme AG Company Information

13.1.2 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product Offered

13.1.3 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 LTS Lohmann Therapie-Systeme AG Main Business Overview

13.1.5 LTS Lohmann Therapie-Systeme AG Latest Developments

13.2 Soligenix

13.2.1 Soligenix Company Information

13.2.2 Soligenix Oral Transmucosal Drugs Product Offered

13.2.3 Soligenix Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Soligenix Main Business Overview

13.2.5 Soligenix Latest Developments

13.3 ZIM Laboratories Limited

13.3.1 ZIM Laboratories Limited Company Information

13.3.2 ZIM Laboratories Limited Oral Transmucosal Drugs Product Offered

13.3.3 ZIM Laboratories Limited Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 ZIM Laboratories Limited Main Business Overview

13.3.5 ZIM Laboratories Limited Latest Developments

13.4 Access Pharmaceutical Inc.

13.4.1 Access Pharmaceutical Inc. Company Information

13.4.2 Access Pharmaceutical Inc. Oral Transmucosal Drugs Product Offered

13.4.3 Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Access Pharmaceutical Inc. Main Business Overview

13.4.5 Access Pharmaceutical Inc. Latest Developments

13.5 C.L Pharm

13.5.1 C.L Pharm Company Information

13.5.2 C.L Pharm Oral Transmucosal Drugs Product Offered

13.5.3 C.L Pharm Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 C.L Pharm Main Business Overview

13.5.5 C.L Pharm Latest Developments

13.6 Cure Pharmaceutical

13.6.1 Cure Pharmaceutical Company Information

13.6.2 Cure Pharmaceutical Oral Transmucosal Drugs Product Offered

13.6.3 Cure Pharmaceutical Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Cure Pharmaceutical Main Business Overview

13.6.5 Cure Pharmaceutical Latest Developments

13.7 Aquestive Therapeutics, Inc.

13.7.1 Aquestive Therapeutics, Inc. Company Information

13.7.2 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product Offered

13.7.3 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Aquestive Therapeutics, Inc. Main Business Overview

13.7.5 Aquestive Therapeutics, Inc. Latest Developments

13.8 NAL Pharma

13.8.1 NAL Pharma Company Information

13.8.2 NAL Pharma Oral Transmucosal Drugs Product Offered

13.8.3 NAL Pharma Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 NAL Pharma Main Business Overview

13.8.5 NAL Pharma Latest Developments

13.9 IntelGenx Corp.

13.9.1 IntelGenx Corp. Company Information

13.9.2 IntelGenx Corp. Oral Transmucosal Drugs Product Offered

13.9.3 IntelGenx Corp. Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 IntelGenx Corp. Main Business Overview

13.9.5 IntelGenx Corp. Latest Developments

13.10 Eisai Co., Ltd.

13.10.1 Eisai Co., Ltd. Company Information

13.10.2 Eisai Co., Ltd. Oral Transmucosal Drugs Product Offered

13.10.3 Eisai Co., Ltd. Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Eisai Co., Ltd. Main Business Overview

13.10.5 Eisai Co., Ltd. Latest Developments

13.11 Otsuka Pharmaceutical Co., Ltd.

13.11.1 Otsuka Pharmaceutical Co., Ltd. Company Information

13.11.2 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product Offered

13.11.3 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Otsuka Pharmaceutical Co., Ltd. Main Business Overview

13.11.5 Otsuka Pharmaceutical Co., Ltd. Latest Developments

13.12 Teva Pharmaceutical Industries Ltd.

13.12.1 Teva Pharmaceutical Industries Ltd. Company Information

13.12.2 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product Offered

13.12.3 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Teva Pharmaceutical Industries Ltd. Main Business Overview

13.12.5 Teva Pharmaceutical Industries Ltd. Latest Developments

13.13 GlaxoSmithKline plc

13.13.1 GlaxoSmithKline plc Company Information

13.13.2 GlaxoSmithKline plc Oral Transmucosal Drugs Product Offered

13.13.3 GlaxoSmithKline plc Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 GlaxoSmithKline plc Main Business Overview

13.13.5 GlaxoSmithKline plc Latest Developments

13.14 Viatris

13.14.1 Viatris Company Information

13.14.2 Viatris Oral Transmucosal Drugs Product Offered

13.14.3 Viatris Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Viatris Main Business Overview

13.14.5 Viatris Latest Developments

13.15 Bristol-Myers Squibb Company

13.15.1 Bristol-Myers Squibb Company Company Information

13.15.2 Bristol-Myers Squibb Company Oral Transmucosal Drugs Product Offered

13.15.3 Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Bristol-Myers Squibb Company Main Business Overview

13.15.5 Bristol-Myers Squibb Company Latest Developments

14 Research Findings and Conclusion

Table 1. Oral Transmucosal Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Oral Transmucosal Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Tablets

Table 4. Major Players of Films

Table 5. Major Players of Liquid Spray

Table 6. Major Players of Gels

Table 7. Major Players of Others

Table 8. Global Oral Transmucosal Drugs Sales by Type (2017-2022) & (K Units)

Table 9. Global Oral Transmucosal Drugs Sales Market Share by Type (2017-2022)

Table 10. Global Oral Transmucosal Drugs Revenue by Type (2017-2022) & ($ million)

Table 11. Global Oral Transmucosal Drugs Revenue Market Share by Type (2017-2022)

Table 12. Global Oral Transmucosal Drugs Sale Price by Type (2017-2022) & (US$/Unit)

Table 13. Global Oral Transmucosal Drugs Sales by Application (2017-2022) & (K Units)

Table 14. Global Oral Transmucosal Drugs Sales Market Share by Application (2017-2022)

Table 15. Global Oral Transmucosal Drugs Revenue by Application (2017-2022)

Table 16. Global Oral Transmucosal Drugs Revenue Market Share by Application (2017-2022)

Table 17. Global Oral Transmucosal Drugs Sale Price by Application (2017-2022) & (US$/Unit)

Table 18. Global Oral Transmucosal Drugs Sales by Company (2020-2022) & (K Units)

Table 19. Global Oral Transmucosal Drugs Sales Market Share by Company (2020-2022)

Table 20. Global Oral Transmucosal Drugs Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Oral Transmucosal Drugs Revenue Market Share by Company (2020-2022)

Table 22. Global Oral Transmucosal Drugs Sale Price by Company (2020-2022) & (US$/Unit)

Table 23. Key Manufacturers Oral Transmucosal Drugs Producing Area Distribution and Sales Area

Table 24. Players Oral Transmucosal Drugs Products Offered

Table 25. Oral Transmucosal Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Oral Transmucosal Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Oral Transmucosal Drugs Sales Market Share Geographic Region (2017-2022)

Table 30. Global Oral Transmucosal Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Oral Transmucosal Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Oral Transmucosal Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Oral Transmucosal Drugs Sales Market Share by Country/Region (2017-2022)

Table 34. Global Oral Transmucosal Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Oral Transmucosal Drugs Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Oral Transmucosal Drugs Sales by Country (2017-2022) & (K Units)

Table 37. Americas Oral Transmucosal Drugs Sales Market Share by Country (2017-2022)

Table 38. Americas Oral Transmucosal Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Oral Transmucosal Drugs Revenue Market Share by Country (2017-2022)

Table 40. Americas Oral Transmucosal Drugs Sales by Type (2017-2022) & (K Units)

Table 41. Americas Oral Transmucosal Drugs Sales Market Share by Type (2017-2022)

Table 42. Americas Oral Transmucosal Drugs Sales by Application (2017-2022) & (K Units)

Table 43. Americas Oral Transmucosal Drugs Sales Market Share by Application (2017-2022)

Table 44. APAC Oral Transmucosal Drugs Sales by Region (2017-2022) & (K Units)

Table 45. APAC Oral Transmucosal Drugs Sales Market Share by Region (2017-2022)

Table 46. APAC Oral Transmucosal Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Oral Transmucosal Drugs Revenue Market Share by Region (2017-2022)

Table 48. APAC Oral Transmucosal Drugs Sales by Type (2017-2022) & (K Units)

Table 49. APAC Oral Transmucosal Drugs Sales Market Share by Type (2017-2022)

Table 50. APAC Oral Transmucosal Drugs Sales by Application (2017-2022) & (K Units)

Table 51. APAC Oral Transmucosal Drugs Sales Market Share by Application (2017-2022)

Table 52. Europe Oral Transmucosal Drugs Sales by Country (2017-2022) & (K Units)

Table 53. Europe Oral Transmucosal Drugs Sales Market Share by Country (2017-2022)

Table 54. Europe Oral Transmucosal Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Oral Transmucosal Drugs Revenue Market Share by Country (2017-2022)

Table 56. Europe Oral Transmucosal Drugs Sales by Type (2017-2022) & (K Units)

Table 57. Europe Oral Transmucosal Drugs Sales Market Share by Type (2017-2022)

Table 58. Europe Oral Transmucosal Drugs Sales by Application (2017-2022) & (K Units)

Table 59. Europe Oral Transmucosal Drugs Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Oral Transmucosal Drugs Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Oral Transmucosal Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Oral Transmucosal Drugs Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Oral Transmucosal Drugs Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Oral Transmucosal Drugs Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Oral Transmucosal Drugs

Table 69. Key Market Challenges & Risks of Oral Transmucosal Drugs

Table 70. Key Industry Trends of Oral Transmucosal Drugs

Table 71. Oral Transmucosal Drugs Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Oral Transmucosal Drugs Distributors List

Table 74. Oral Transmucosal Drugs Customer List

Table 75. Global Oral Transmucosal Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Oral Transmucosal Drugs Sales Market Forecast by Region

Table 77. Global Oral Transmucosal Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Oral Transmucosal Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Oral Transmucosal Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Oral Transmucosal Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Oral Transmucosal Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Oral Transmucosal Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Oral Transmucosal Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Oral Transmucosal Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Oral Transmucosal Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Oral Transmucosal Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Oral Transmucosal Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Oral Transmucosal Drugs Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Oral Transmucosal Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Oral Transmucosal Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Oral Transmucosal Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Oral Transmucosal Drugs Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Oral Transmucosal Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Oral Transmucosal Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 95. LTS Lohmann Therapie-Systeme AG Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 96. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product Offered

Table 97. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 98. LTS Lohmann Therapie-Systeme AG Main Business

Table 99. LTS Lohmann Therapie-Systeme AG Latest Developments

Table 100. Soligenix Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 101. Soligenix Oral Transmucosal Drugs Product Offered

Table 102. Soligenix Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 103. Soligenix Main Business

Table 104. Soligenix Latest Developments

Table 105. ZIM Laboratories Limited Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 106. ZIM Laboratories Limited Oral Transmucosal Drugs Product Offered

Table 107. ZIM Laboratories Limited Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 108. ZIM Laboratories Limited Main Business

Table 109. ZIM Laboratories Limited Latest Developments

Table 110. Access Pharmaceutical Inc. Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 111. Access Pharmaceutical Inc. Oral Transmucosal Drugs Product Offered

Table 112. Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 113. Access Pharmaceutical Inc. Main Business

Table 114. Access Pharmaceutical Inc. Latest Developments

Table 115. C.L Pharm Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 116. C.L Pharm Oral Transmucosal Drugs Product Offered

Table 117. C.L Pharm Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 118. C.L Pharm Main Business

Table 119. C.L Pharm Latest Developments

Table 120. Cure Pharmaceutical Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 121. Cure Pharmaceutical Oral Transmucosal Drugs Product Offered

Table 122. Cure Pharmaceutical Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 123. Cure Pharmaceutical Main Business

Table 124. Cure Pharmaceutical Latest Developments

Table 125. Aquestive Therapeutics, Inc. Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 126. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product Offered

Table 127. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 128. Aquestive Therapeutics, Inc. Main Business

Table 129. Aquestive Therapeutics, Inc. Latest Developments

Table 130. NAL Pharma Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 131. NAL Pharma Oral Transmucosal Drugs Product Offered

Table 132. NAL Pharma Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 133. NAL Pharma Main Business

Table 134. NAL Pharma Latest Developments

Table 135. IntelGenx Corp. Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 136. IntelGenx Corp. Oral Transmucosal Drugs Product Offered

Table 137. IntelGenx Corp. Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 138. IntelGenx Corp. Main Business

Table 139. IntelGenx Corp. Latest Developments

Table 140. Eisai Co., Ltd. Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 141. Eisai Co., Ltd. Oral Transmucosal Drugs Product Offered

Table 142. Eisai Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 143. Eisai Co., Ltd. Main Business

Table 144. Eisai Co., Ltd. Latest Developments

Table 145. Otsuka Pharmaceutical Co., Ltd. Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 146. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product Offered

Table 147. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 148. Otsuka Pharmaceutical Co., Ltd. Main Business

Table 149. Otsuka Pharmaceutical Co., Ltd. Latest Developments

Table 150. Teva Pharmaceutical Industries Ltd. Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 151. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product Offered

Table 152. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 153. Teva Pharmaceutical Industries Ltd. Main Business

Table 154. Teva Pharmaceutical Industries Ltd. Latest Developments

Table 155. GlaxoSmithKline plc Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 156. GlaxoSmithKline plc Oral Transmucosal Drugs Product Offered

Table 157. GlaxoSmithKline plc Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 158. GlaxoSmithKline plc Main Business

Table 159. GlaxoSmithKline plc Latest Developments

Table 160. Viatris Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 161. Viatris Oral Transmucosal Drugs Product Offered

Table 162. Viatris Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 163. Viatris Main Business

Table 164. Viatris Latest Developments

Table 165. Bristol-Myers Squibb Company Basic Information, Oral Transmucosal Drugs Manufacturing Base, Sales Area and Its Competitors

Table 166. Bristol-Myers Squibb Company Oral Transmucosal Drugs Product Offered

Table 167. Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 168. Bristol-Myers Squibb Company Main Business

Table 169. Bristol-Myers Squibb Company Latest Developments

List of Figures

Figure 1. Picture of Oral Transmucosal Drugs

Figure 2. Oral Transmucosal Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Oral Transmucosal Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Oral Transmucosal Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Oral Transmucosal Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Tablets

Figure 10. Product Picture of Films

Figure 11. Product Picture of Liquid Spray

Figure 12. Product Picture of Gels

Figure 13. Product Picture of Others

Figure 14. Global Oral Transmucosal Drugs Sales Market Share by Type in 2021

Figure 15. Global Oral Transmucosal Drugs Revenue Market Share by Type (2017-2022)

Figure 16. Oral Transmucosal Drugs Consumed in Cardiovascular Disorders

Figure 17. Global Oral Transmucosal Drugs Market: Cardiovascular Disorders (2017-2022) & (K Units)

Figure 18. Oral Transmucosal Drugs Consumed in Acute Pain Managements

Figure 19. Global Oral Transmucosal Drugs Market: Acute Pain Managements (2017-2022) & (K Units)

Figure 20. Oral Transmucosal Drugs Consumed in Diabetes

Figure 21. Global Oral Transmucosal Drugs Market: Diabetes (2017-2022) & (K Units)

Figure 22. Oral Transmucosal Drugs Consumed in Others

Figure 23. Global Oral Transmucosal Drugs Market: Others (2017-2022) & (K Units)

Figure 24. Global Oral Transmucosal Drugs Sales Market Share by Application (2017-2022)

Figure 25. Global Oral Transmucosal Drugs Revenue Market Share by Application in 2021

Figure 26. Oral Transmucosal Drugs Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Oral Transmucosal Drugs Revenue Market Share by Company in 2021

Figure 28. Global Oral Transmucosal Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Oral Transmucosal Drugs Revenue Market Share by Geographic Region in 2021

Figure 30. Global Oral Transmucosal Drugs Sales Market Share by Region (2017-2022)

Figure 31. Global Oral Transmucosal Drugs Revenue Market Share by Country/Region in 2021

Figure 32. Americas Oral Transmucosal Drugs Sales 2017-2022 (K Units)

Figure 33. Americas Oral Transmucosal Drugs Revenue 2017-2022 ($ Millions)

Figure 34. APAC Oral Transmucosal Drugs Sales 2017-2022 (K Units)

Figure 35. APAC Oral Transmucosal Drugs Revenue 2017-2022 ($ Millions)

Figure 36. Europe Oral Transmucosal Drugs Sales 2017-2022 (K Units)

Figure 37. Europe Oral Transmucosal Drugs Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Oral Transmucosal Drugs Sales 2017-2022 (K Units)

Figure 39. Middle East & Africa Oral Transmucosal Drugs Revenue 2017-2022 ($ Millions)

Figure 40. Americas Oral Transmucosal Drugs Sales Market Share by Country in 2021

Figure 41. Americas Oral Transmucosal Drugs Revenue Market Share by Country in 2021

Figure 42. United States Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Oral Transmucosal Drugs Sales Market Share by Region in 2021

Figure 47. APAC Oral Transmucosal Drugs Revenue Market Share by Regions in 2021

Figure 48. China Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Oral Transmucosal Drugs Sales Market Share by Country in 2021

Figure 55. Europe Oral Transmucosal Drugs Revenue Market Share by Country in 2021

Figure 56. Germany Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Oral Transmucosal Drugs Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Oral Transmucosal Drugs Revenue Market Share by Country in 2021

Figure 63. Egypt Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Oral Transmucosal Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Oral Transmucosal Drugs in 2021

Figure 69. Manufacturing Process Analysis of Oral Transmucosal Drugs

Figure 70. Industry Chain Structure of Oral Transmucosal Drugs

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles